z-logo
open-access-imgOpen Access
Copanlisib + Rituximab Shows Superior Efficacy in Marginal Zone Lymphoma
Author(s) -
Catlin Nalley
Publication year - 2021
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000802816.91563.6a
Subject(s) - rituximab , medicine , lymphoma , oncology , placebo , gastroenterology , pathology , alternative medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here